John Lansing's Trending123
John Lansing's Trending123
Username: Password: Login
Trade Talk E-Letter Products & Services Trading Tools Portfolios Members Home
Enter Symbol:
Drug Manufacturers Other
MLNM @ Yahoo Finance
MLNM Option @ Yahoo Finance
Stock Details
Current Price High Value Change Percent Change Dividend Previous Close
$ 14.66 $ 14.73 $ 0.49 3.46% 0.00 $ 14.17
Opening Price Low Volume Market Cap Average Volume P/E
$ 14.32 $ 14.26 8.32M 4.73B 5.7M 77.16
Pivot Table
R2 R1 Pivot S1 S2
15.02 14.84 14.55 14.37 14.08

stock chart

Millennium Pharmaceuticals, Inc. engages in the research, development, and commercialization of therapeutic products in the areas of cancer, cardiovascular, and inflammatory diseases. The company's products include VELCADE, a proteasome inhibitor for treating patients with multiple myeloma; and INTEGRILIN injection, a cardiovascular product. Its INTEGRILIN injection prevents aggregation of blood platelets and occlusion of the arteries supplying the heart muscle with oxygen to prevent the incidence of heart attack or death in patients with acute coronary syndrome, and for the treatment of patients undergoing percutaneous coronary intervention. The company's preclinical and clinical development drug candidates include MLN2704 for prostate cancer; MLN518 for acute myeloid leukemia; MLN8054 for solid tumor cancers; MLN2222 for reperfusion injury in patients undergoing cardiac surgeries; MLN1202 for rheumatoid arthritis multiple sclerosis; MLN3897 for chronic inflammatory diseases, such as rheumatoid arthritis; MLN02 for Crohn's disease; and MLN3701 for chronic inflammatory diseases, such as rheumatoid arthritis. It has strategic alliances with Ortho Biotech Products, L.P.; Schering-Plough, Ltd.; GlaxoSmithKline plc; Aventis Pharma; and Schering Corporation. Millennium Pharmaceuticals was founded in 1993 and is headquartered in Cambridge, Massachusetts.

  • Premarket, intraday, nightly, and weekend updates, which include stock picks with full instructions, market direction (short, intermediate, long term), precious metal, commodity, and currency analysis.
  • Provide you stock picks (breakouts) and market direction to help you become
    more profitable.

  • Voice over chart updates sent to you by e-mail. These updates contain stock picks and market status for a number of different portfolios, which Trending123 is recommending and following.
  • Instantaneous e-mail alerts during the trading day when targets have been hit or the status of a position or the market warrants a move. Stock Recommendations for swing traders, day traders, and long term investors.
  • Receive instant emails to your computer, organizer, cell phone of breakouts on stocks.....Learn More